BMJ  2007;334:647-648 (31 March), doi:10.1136/bmj.39149.369329.80

Editorials

Acute coronary syndrome

Glycoprotein IIb/IIIa inhibitors are still underused, especially in patients at high risk

The first 150 words of the full text of this article appear below.

About 120 000 people are diagnosed with acute coronary syndrome in England and Wales each year, and about 1.5 million people are discharged from hospitals in the United States with the diagnosis.1 Despite the use of standard medical treatment, the risk of death or non-fatal myocardial infarction is about 10% within 30 days, and the proportion of adverse outcomes is about 30% at six months.2

Doctors who deal with acute medical admissions are well accustomed to the diagnosis and initial medical management of acute coronary syndromes. However, many doctors are less confident about the use of glycoprotein IIb/IIIa inhibitors, such as eptifibatide and tirofiban, in these patients and often await a cardiology review.3 This may be less important in tertiary centres where a specialist opinion is prompt and patients at high risk are quickly identified and stratified to invasive strategies or coronary care units. In district general hospitals, however, the . . . [Full text of this article]

A Khavandi, cardiology specialist registrar, P R Walker, consultant cardiologist

Southmead Hospital, North Bristol NHS Teaching Trust, Bristol BS10 5NB

Khavandi@Hotmail.com


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Rapid Responses:

Read all Rapid Responses

Anti-platelets in acute coronary syndromes: too much of a good thing?
Damian J Kelly, et al.
bmj.com, 2 Apr 2007 [Full text]
Increased bleeding, recurrent myocardial infarction and death with glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia
Amit Patel
bmj.com, 3 Apr 2007 [Full text]
GP2b/3a blockers do not save lives.
David L Murdoch
bmj.com, 5 Apr 2007 [Full text]
Perhaps now and again more represents less
Dr. Filip Konecny
bmj.com, 3 Jul 2007 [Full text]
Access jobs at BMJ Careers
Whats new online at Student BMJ